Braveheart Bio (BRVE) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket
 


Braveheart Bio, Inc.  (Nasdaq: BRVE)

Braveheart Bio Profitability Comparisons

Select each Category to receive further Information




BRVE Profitability Ratio

Company Industry Sector S&P 500
Gross Profit Margin (Q3 MRQ) - 65.6 % 52.83 % 35.16 %
Gross Margin (Q3 TTM) - 68.42 % 55.11 % 37.95 %
Gross Profit Margin 5 Yr. Avg. - 54.59 % 50.07 % 26.63 %
EBITDA Margin (Q3 MRQ) - 27.77 % 21.53 % 26.05 %
EBITDA Margin (Q3 TTM) - 27.93 % 23.01 % 23.38 %
EBITDA Margin 5 Yr. Avg. - 22.66 % 20.31 % 11.84 %
Operating Margin (Q3 MRQ) - 8.6 % 6.87 % 13.18 %
Operating Margin (Q3 TTM) - 6.17 % 7.37 % 12.23 %
Operating Margin 5 Yr. Avg. - 18.61 % 12.01 % 8.21 %
Pre-Tax Profit Margin (Q3 MRQ) - 16.62 % 10.75 % 18.02 %
Pre-Tax Profit Margin (Q3 TTM) - 16.69 % 12.41 % 14.52 %
Pre-Tax Profit Margin 5 Yr. Avg. - 21.15 % 12.2 % 8.29 %
Net Margin (Q3 MRQ) - 11.97 % 9.43 % 15.21 %
Net Margin (Q3 TTM) - 12.37 % 9.6 % 12.3 %
Net Margin 5 Yr. Avg. - 15.99 % 7.99 % 6.33 %



Company's Cashflow Profitability & Other



Profitability Ratios Company Industry Sector S&P 500
Free Cash Flow Margin (Q3 MRQ) - -0.09 % -0.06 % 0 %
Free Cash Flow Margin (Q3 TTM) - 19.02 % 15.39 % 10.05 %
Free Cash Flow Margin 5 Yr. Avg. - 22.22 % 13.86 % 9.05 %
Net Cash Flow Margin (Q3 MRQ) - 0.21 % 0.1 % 0 %
Net Cash Flow Margin (Q3 TTM) - 1.17 % 0.96 % 1.44 %
Net Cash Flow Margin 5 Yr. Avg. - 0.26 % 1.42 % 1.4 %
Effective Tax Rate (Q3 MRQ) - 25.87 % 31.95 % 21.08 %
Effective Tax Rate (Q3 TTM)